Cargando…
Adoption of Pharmacogenomic Testing: A Marketing Perspective
Pharmacogenomics is becoming an important part of clinical practice and it is considered one of the basic pillars of personalised medicine. However, the rate of pharmacogenomics adoption is still low in many healthcare systems, especially in low- or middle-income countries. The low level of awarenes...
Autores principales: | Koufaki, Margarita-Ioanna, Karamperis, Kariofyllis, Vitsa, Polixeni, Vasileiou, Konstantinos, Patrinos, George P., Mitropoulou, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484788/ https://www.ncbi.nlm.nih.gov/pubmed/34603034 http://dx.doi.org/10.3389/fphar.2021.724311 |
Ejemplares similares
-
Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2023) -
Examining key factors impact on health science students’ intentions to adopt genetic and pharmacogenomics testing: a comparative path analysis in two different healthcare settings
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2022) -
Pharmacy students’ attitudes and intentions of pursuing postgraduate studies and training in pharmacogenomics and personalised medicine
por: Makrygianni, Dimitra, et al.
Publicado: (2023) -
Genome-based therapeutic interventions for β-type hemoglobinopathies
por: Karamperis, Kariofyllis, et al.
Publicado: (2021) -
Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow
por: Giannopoulou, Efstathia, et al.
Publicado: (2019)